NASDAQ:CDIO Cardio Diagnostics (CDIO) Stock Price, News & Analysis $0.47 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.44▼$0.4850-Day Range$0.47▼$0.7352-Week Range$0.17▼$3.56Volume186,980 shsAverage Volume731,668 shsMarket Capitalization$10.62 millionP/E RatioN/ADividend YieldN/APrice Target$2.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Cardio Diagnostics alerts: Email Address Cardio Diagnostics MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside327.2% Upside$2.00 Price TargetShort InterestHealthy1.57% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.96Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.96 out of 5 starsMedical Sector419th out of 936 stocksDiagnostic Substances Industry7th out of 15 stocks 3.5 Analyst's Opinion Consensus RatingCardio Diagnostics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageCardio Diagnostics has only been the subject of 1 research reports in the past 90 days.Read more about Cardio Diagnostics' stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.57% of the float of Cardio Diagnostics has been sold short.Short Interest Ratio / Days to CoverCardio Diagnostics has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cardio Diagnostics has recently decreased by 34.19%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldCardio Diagnostics does not currently pay a dividend.Dividend GrowthCardio Diagnostics does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CDIO. Previous Next 3.3 News and Social Media Coverage News SentimentCardio Diagnostics has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Cardio Diagnostics this week, compared to 1 article on an average week.Search Interest4 people have searched for CDIO on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added Cardio Diagnostics to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cardio Diagnostics insiders have not sold or bought any company stock.Percentage Held by Insiders30.00% of the stock of Cardio Diagnostics is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 8.06% of the stock of Cardio Diagnostics is held by institutions.Read more about Cardio Diagnostics' insider trading history. Previous Next 0.0 Earnings and Valuation Price to Book Value per Share RatioCardio Diagnostics has a P/B Ratio of 3.34. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad InvestorPlaceBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… About Cardio Diagnostics Stock (NASDAQ:CDIO)Cardio Diagnostics Holdings, Inc., an artificial intelligence-powered precision cardiovascular medicine company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. The company was founded in 2017 and is headquartered in Chicago, Illinois.Read More CDIO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CDIO Stock News HeadlinesJuly 25 at 2:22 AM | americanbankingnews.comCardio Diagnostics (NASDAQ:CDIO) Stock Price Down 3.9%June 25, 2024 | businesswire.comCardio Diagnostics Announces It's Exhibiting at the 2024 Onsite Employee Health Clinics ForumJuly 26, 2024 | InvestorPlace (Ad)Breaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.June 21, 2024 | investorplace.comCDIO Stock Earnings: Cardio Diagnostics Hldgs Misses EPS, Misses Revenue for Q1 2024June 10, 2024 | businesswire.comCardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and ConfidentialityMay 21, 2024 | msn.comNew cardio suite to allow more tests at hospitalMay 21, 2024 | finance.yahoo.comCardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services’ (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative TestsMay 17, 2024 | morningstar.comCardio Diagnostics Holdings Inc CDIOJuly 26, 2024 | InvestorPlace (Ad)Breaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.May 13, 2024 | finance.yahoo.comCardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists’ Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a WeekMay 13, 2024 | businesswire.comCardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists' Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a WeekApril 29, 2024 | msn.comMeta-analysis finds cardio-fitness cuts death and disease by nearly 20%April 29, 2024 | businesswire.comCardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers Over $113 Million AnnuallyApril 9, 2024 | businesswire.comExponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in MichiganApril 4, 2024 | markets.businessinsider.comCardio Diagnostics Inks Nationwide Telehealth Deal With NavierreApril 4, 2024 | businesswire.comCardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with NavierreApril 3, 2024 | finance.yahoo.comCardio Diagnostics Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues LagMarch 18, 2024 | msn.comPotential novel biomarkers of coronary heart disease discoveredSee More Headlines Receive CDIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardio Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic substances Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:CDIO CUSIPN/A CIK1870144 Webcardiodiagnosticsinc.com Phone302-281-2147FaxN/AEmployees1Year FoundedN/APrice Target and Rating Average Stock Price Target$2.00 High Stock Price Target$2.00 Low Stock Price Target$2.00 Potential Upside/Downside+327.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,380,000.00 Net Margins-34,911.87% Pretax Margin-34,911.87% Return on Equity-415.33% Return on Assets-216.10% Debt Debt-to-Equity RatioN/A Current Ratio3.77 Quick Ratio3.77 Sales & Book Value Annual Sales$20,000.00 Price / Sales531.17 Cash FlowN/A Price / Cash FlowN/A Book Value$0.14 per share Price / Book3.34Miscellaneous Outstanding Shares22,690,000Free Float15,880,000Market Cap$10.62 million OptionableNot Optionable Beta4.95 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesDr. Meeshanthini V. Dogan Ph.D. (Age 35)Co-Founder, CEO & Director Comp: $307.25kMs. Elisa Michael Luqman Esq. (Age 60)J.D., M.B.A., Chief Financial Officer Comp: $275kDr. Robert A. Philibert M.D. (Age 62)Ph.D., Co-Founder, Chief Medical Officer & Director Mr. Timur Dogan Ph.D. (Age 36)Chief Technology Officer Ms. Khullani Abdullahi J.D. (Age 40)Vice President of Revenue & Strategy Key CompetitorsMicroAlgoNASDAQ:MLGOSAI.TECH GlobalNASDAQ:SAIArisz AcquisitionNASDAQ:ARIZMountain Crest Acquisition Corp. VNASDAQ:MCAGLakeshore BiopharmaNASDAQ:LSBView All CompetitorsInsidersMeeshanthini DoganBought 16,481 shares on 8/31/2023Total: $9,064.55 ($0.55/share)Robert PhilibertBought 18,000 shares on 8/28/2023Total: $10,800.00 ($0.60/share)Meeshanthini DoganBought 1,770 shares on 8/25/2023Total: $991.20 ($0.56/share)Robert PhilibertBought 16,000 shares on 8/24/2023Total: $9,600.00 ($0.60/share)View All Insider Transactions CDIO Stock Analysis - Frequently Asked Questions How have CDIO shares performed this year? Cardio Diagnostics' stock was trading at $2.49 on January 1st, 2024. Since then, CDIO stock has decreased by 81.2% and is now trading at $0.4682. View the best growth stocks for 2024 here. How do I buy shares of Cardio Diagnostics? Shares of CDIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CDIO) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardio Diagnostics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardio Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
